Protein engineering of a novel constitutively active hormone-receptor complex

J Biol Chem. 1996 Dec 6;271(49):31638-42. doi: 10.1074/jbc.271.49.31638.

Abstract

Human chorionic gonadotropin (hCG) is a heterodimeric glycoprotein hormone consisting of an alpha and a beta subunit that stimulates intracellular levels of cAMP via a G protein-coupled receptor. Herein we report the engineering and characterization of a novel molecule in which the receptor and its heterodimeric ligand were covalently linked in a single polypeptide chain. The hormone-receptor complex was expressed in cells transfected with this construct, but the cells were unable to bind significant amounts of exogenous hCG. However, cleavage of the hormone with a site-specific protease rendered the receptor accessible to exogenously added hormone. Cells transfected with the hCG-receptor construct contained elevated basal levels of cAMP; moreover, addition of hormone had no significant effect. These results are consistent with a strong and stable interaction between the single-chain hormone and its covalently linked receptor that results in a constitutively active complex.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • COS Cells
  • Cell Line
  • Chorionic Gonadotropin / chemistry*
  • Cyclic AMP / metabolism
  • Dose-Response Relationship, Drug
  • Humans
  • Protein Conformation
  • Protein Engineering*
  • Receptors, Gonadotropin / metabolism
  • Receptors, LH / chemistry*
  • Receptors, LH / genetics
  • Recombinant Fusion Proteins*
  • Restriction Mapping
  • Transfection

Substances

  • Chorionic Gonadotropin
  • Receptors, Gonadotropin
  • Receptors, LH
  • Recombinant Fusion Proteins
  • yoked hormone receptor, recombinant
  • Cyclic AMP